These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease. Sweet RD; Lee JE; McDowell F Trans Am Neurol Assoc; 1971; 96():59-65. PubMed ID: 5159130 [No Abstract] [Full Text] [Related]
3. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine]. Sigwald J; Raymondeaud C; Piot C Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718 [No Abstract] [Full Text] [Related]
4. [L-Dopa therapy in Parkinson's disease. A double-blind study]. Worm-Petersen J; Dupont E; Mikkelsen B Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651 [No Abstract] [Full Text] [Related]
5. A year's experience of L-DOPA in the treatment of Parkinson's disease. Guidetti B; Giuffrè R Acta Neurochir (Wien); 1971; 24(2):81-8. PubMed ID: 5112463 [No Abstract] [Full Text] [Related]
6. Long-term treatment of Parkinsonism with L-dopa. Presthus J; Holmsen R Acta Neurol Scand Suppl; 1972; 51():131-2. PubMed ID: 4514340 [No Abstract] [Full Text] [Related]
7. The clinical use of levodopa in the treatment of Parkinson's disease. McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056 [No Abstract] [Full Text] [Related]
8. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486). Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129 [No Abstract] [Full Text] [Related]
9. Treatment of Parkinson's disease with L-dopa: a current appraisal. Kofman O Can Med Assoc J; 1971 Mar; 104(6):483-7. PubMed ID: 5549988 [TBL] [Abstract][Full Text] [Related]
11. A double blind study of 1-dopa treatment in Parkinson's disease. Rinne UK; Sonninen V Eur Neurol; 1968; 1(3):180-91. PubMed ID: 4880674 [No Abstract] [Full Text] [Related]
12. 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease. Muenter MD; Dinapoli RP; Sharpless NS; Tyce GM Mayo Clin Proc; 1973 Mar; 48(3):173-83. PubMed ID: 4570387 [No Abstract] [Full Text] [Related]
13. [Psychic manifestations during treatment of Parkinson's disease with L-dopa]. Bonduelle M Rev Neurol (Paris); 1970 Feb; 122(2):140. PubMed ID: 5517897 [No Abstract] [Full Text] [Related]
14. [Treatment of parkinsonism with the drug L-DOPA]. Stoliarova LG; Kistenev BA Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170 [No Abstract] [Full Text] [Related]
15. [Study of L-dopa treatment and its principal side effects in aged subjects]. Antonini F; Baroni A; Bucalossi A; Roveyaz L Gerontol Clin (Basel); 1972; 14(5):297-309. PubMed ID: 4144357 [No Abstract] [Full Text] [Related]